J Knee Surg 2019; 32(01): 055-064
DOI: 10.1055/s-0038-1672155
Special Focus Section
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Adipose-Based Therapies for Knee Pain—Fat or Fiction

Yoshiharu Shimozono
1   Foot and Ankle Service, Hospital for Special Surgery, New York, New York
,
Lisa A. Fortier
2   Department of Clinical Sciences, Cornell University, Ithaca, New York
,
Donald Brown
3   Department of Orthobiologics, Isto Biologics, Hopkinton, Massachusetts
,
John G. Kennedy
1   Foot and Ankle Service, Hospital for Special Surgery, New York, New York
› Author Affiliations
Further Information

Publication History

10 July 2018

15 August 2018

Publication Date:
30 November 2018 (online)

Abstract

Regenerative cell therapies are emerging as promising treatments for numerous musculoskeletal conditions, including knee osteoarthritis (OA). Adipose-derived stem cells and possibly other adipose-based therapies have a greater chondrogenic potential than stem cells derived from bone marrow, and thus a lot of attention is being placed on them as potential regenerative agents in the treatment of knee OA. Several types of adipose-based therapies have good basic science and preclinical data supporting their translation to human therapeutic intervention. Cultured, adipose-derived stem cells appear to be good source of bioactive cells with convenient accessibility, relative abundance, and well-documented regenerative capacity. Non-culture expanded adipose-based therapy, in the forms of stromal vascular fraction and most recently micronized adipose tissue (MAT), have been utilized in patients to treat OA and other cartilage abnormalities with encouraging preliminary data. These adipose-based therapies have shown a lot of therapeutic potential; however, because of the regulatory restrictions on enzymatic isolation and cell expansion, only MAT is currently available in clinical practice in the United States. While no serious adverse reactions have been reported, adipose-derived therapies also have the potential for adverse reactions including inflammation and infection. The current review provides an update on the latest research and presents this evidence on the therapeutic potential of adipose-based therapies in the treatment of knee OA.

 
  • References

  • 1 Soni A, Kiran A, Hart DJ. , et al. Prevalence of reported knee pain over twelve years in a community-based cohort. Arthritis Rheum 2012; 64 (04) 1145-1152
  • 2 Nguyen US, Zhang Y, Zhu Y, Niu J, Zhang B, Felson DT. Increasing prevalence of knee pain and symptomatic knee osteoarthritis: survey and cohort data. Ann Intern Med 2011; 155 (11) 725-732
  • 3 Bhatia D, Bejarano T, Novo M. Current interventions in the management of knee osteoarthritis. J Pharm Bioallied Sci 2013; 5 (01) 30-38
  • 4 Caplan AI. Mesenchymal stem cells: time to change the name!. Stem Cells Transl Med 2017; 6 (06) 1445-1451
  • 5 Bianchi F, Maioli M, Leonardi E. , et al. A new nonenzymatic method and device to obtain a fat tissue derivative highly enriched in pericyte-like elements by mild mechanical forces from human lipoaspirates. Cell Transplant 2013; 22 (11) 2063-2077
  • 6 Tremolada C, Colombo V, Ventura C. Adipose tissue and mesenchymal stem cells: state of the art and Lipogems® technology development. Curr Stem Cell Rep 2016; 2: 304-312
  • 7 Somoza RA, Welter JF, Correa D, Caplan AI. Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations. Tissue Eng Part B Rev 2014; 20 (06) 596-608
  • 8 Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C. Adipose-derived stem cells: isolation, expansion and differentiation. Methods 2008; 45 (02) 115-120
  • 9 Aronowitz JA, Lockhart RA, Hakakian CS. Mechanical versus enzymatic isolation of stromal vascular fraction cells from adipose tissue. Springerplus 2015; 4: 713
  • 10 Mashiko T, Wu SH, Feng J. , et al. Mechanical micronization of lipoaspirates: squeeze and emulsification techniques. Plast Reconstr Surg 2017; 139 (01) 79-90
  • 11 Singh A, Goel SC, Gupta KK. , et al. The role of stem cells in osteoarthritis: An experimental study in rabbits. Bone Joint Res 2014; 3 (02) 32-37
  • 12 González-Cruz RD, Darling EM. Adipose-derived stem cell fate is predicted by cellular mechanical properties. Adipocyte 2013; 2 (02) 87-91
  • 13 Francis SL, Duchi S, Onofrillo C, Di Bella C, Choong PFM. Adipose-derived mesenchymal stem cells in the use of cartilage tissue engineering: the need for a rapid isolation procedure. Stem Cells Int 2018; 2018: 8947548
  • 14 Buckley CT, Vinardell T, Thorpe SD. , et al. Functional properties of cartilaginous tissues engineered from infrapatellar fat pad-derived mesenchymal stem cells. J Biomech 2010; 43 (05) 920-926
  • 15 Hindle P, Khan N, Biant L, Péault B. The infrapatellar fat pad as a source of perivascular stem cells with increased chondrogenic potential for regenerative medicine. Stem Cells Transl Med 2017; 6 (01) 77-87
  • 16 Lopa S, Colombini A, Stanco D, de Girolamo L, Sansone V, Moretti M. Donor-matched mesenchymal stem cells from knee infrapatellar and subcutaneous adipose tissue of osteoarthritic donors display differential chondrogenic and osteogenic commitment. Eur Cell Mater 2014; 27: 298-311
  • 17 Felimban R, Ye K, Traianedes K. , et al. Differentiation of stem cells from human infrapatellar fat pad: characterization of cells undergoing chondrogenesis. Tissue Eng Part A 2014; 20 (15-16): 2213-2223
  • 18 Tangchitphisut P, Srikaew N, Numhom S. , et al. Infrapatellar fat pad: an alternative source of adipose-derived mesenchymal stem cells. Arthritis (Egypt) 2016; 2016: 4019873
  • 19 Seaman SA, Tannan SC, Cao Y, Peirce SM, Lin KY. Differential effects of processing time and duration of collagenase digestion on human and murine fat grafts. Plast Reconstr Surg 2015; 136 (02) 189e-199e
  • 20 Schneider S, Unger M, van Griensven M, Balmayor ER. Adipose-derived mesenchymal stem cells from liposuction and resected fat are feasible sources for regenerative medicine. Eur J Med Res 2017; 22 (01) 17
  • 21 Wankhade UD, Shen M, Kolhe R, Fulzele S. Advances in adipose-derived stem cells isolation, characterization, and application in regenerative tissue engineering. Stem Cells Int 2016; 2016: 3206807
  • 22 Zuk PA, Zhu M, Ashjian P. , et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13 (12) 4279-4295
  • 23 Bourin P, Bunnell BA, Casteilla L. , et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 2013; 15 (06) 641-648
  • 24 Estes BT, Diekman BO, Gimble JM, Guilak F. Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc 2010; 5 (07) 1294-1311
  • 25 Im GI, Jung NH, Tae SK. Chondrogenic differentiation of mesenchymal stem cells isolated from patients in late adulthood: the optimal conditions of growth factors. Tissue Eng 2006; 12 (03) 527-536
  • 26 Kolambkar YM, Peister A, Soker S, Atala A, Guldberg RE. Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol 2007; 38 (05) 405-413
  • 27 Sukarto A, Yu C, Flynn LE, Amsden BG. Co-delivery of adipose-derived stem cells and growth factor-loaded microspheres in RGD-grafted N-methacrylate glycol chitosan gels for focal chondral repair. Biomacromolecules 2012; 13 (08) 2490-2502
  • 28 He F, Pei M. Extracellular matrix enhances differentiation of adipose stem cells from infrapatellar fat pad toward chondrogenesis. J Tissue Eng Regen Med 2013; 7 (01) 73-84
  • 29 Yin F, Cai J, Zen W. , et al. Cartilage regeneration of adipose-derived stem cells in the TGF-β1-immobilized PLGA-gelatin scaffold. Stem Cell Rev 2015; 11 (03) 453-459
  • 30 Zhang K, Yan S, Li G, Cui L, Yin J. In-situ birth of MSCs multicellular spheroids in poly(L-glutamic acid)/chitosan scaffold for hyaline-like cartilage regeneration. Biomaterials 2015; 71: 24-34
  • 31 Kim YS, Choi YJ, Suh DS. , et al. Mesenchymal stem cell implantation in osteoarthritic knees: is fibrin glue effective as a scaffold?. Am J Sports Med 2015; 43 (01) 176-185
  • 32 Pers YM, Rackwitz L, Ferreira R. , et al; ADIPOA Consortium. Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase I dose-escalation trial. Stem Cells Transl Med 2016; 5 (07) 847-856
  • 33 Jo CH, Chai JW, Jeong EC. , et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a 2-year follow-up study. Am J Sports Med 2017; 45 (12) 2774-2783
  • 34 Spasovski D, Spasovski V, Baščarević Z. , et al. Intra-articular injection of autologous adipose-derived mesenchymal stem cells in the treatment of knee osteoarthritis. J Gene Med 2018;20(1). Doi: 10.1002/jgm.300
  • 35 Pak J, Lee JH, Kartolo WA, Lee SH. Cartilage regeneration in human with adipose tissue-derived stem cells: current status in clinical implications. BioMed Res Int 2016; 2016: 4702674
  • 36 Pires de Carvalho P, Hamel KM, Duarte R. , et al. Comparison of infrapatellar and subcutaneous adipose tissue stromal vascular fraction and stromal/stem cells in osteoarthritic subjects. J Tissue Eng Regen Med 2014; 8 (10) 757-762
  • 37 Han J, Koh YJ, Moon HR. , et al. Adipose tissue is an extramedullary reservoir for functional hematopoietic stem and progenitor cells. Blood 2010; 115 (05) 957-964
  • 38 Charles-de-Sá L, Gontijo-de-Amorim NF, Maeda Takiya C. , et al. Antiaging treatment of the facial skin by fat graft and adipose-derived stem cells. Plast Reconstr Surg 2015; 135 (04) 999-1009
  • 39 van Dijk A, Naaijkens BA, Jurgens WJ. , et al. Reduction of infarct size by intravenous injection of uncultured adipose derived stromal cells in a rat model is dependent on the time point of application. Stem Cell Res (Amst) 2011; 7 (03) 219-229
  • 40 Matsumoto D, Sato K, Gonda K. , et al. Cell-assisted lipotransfer: supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection. Tissue Eng 2006; 12 (12) 3375-3382
  • 41 Zuk PA, Zhu M, Mizuno H. , et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7 (02) 211-228
  • 42 Jurgens WJ, van Dijk A, Doulabi BZ. , et al. Freshly isolated stromal cells from the infrapatellar fat pad are suitable for a one-step surgical procedure to regenerate cartilage tissue. Cytotherapy 2009; 11 (08) 1052-1064
  • 43 Wu L, Prins HJ, Leijten J. , et al. Chondrocytes cocultured with stromal vascular fraction of adipose tissue present more intense chondrogenic characteristics than with adipose stem cells. Tissue Eng Part A 2016; 22 (3-4): 336-348
  • 44 Hurley ET, Yasui Y, Gianakos AL. , et al. Limited evidence for adipose-derived stem cell therapy on the treatment of osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2018. Doi: 10.1007/s00167-018-4955-x
  • 45 Pak J, Chang JJ, Lee JH, Lee SH. Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints. BMC Musculoskelet Disord 2013; 14: 337
  • 46 Koh YG, Choi YJ, Kwon OR, Kim YS. Second-look arthroscopic evaluation of cartilage lesions after mesenchymal stem cell implantation in osteoarthritic knees. Am J Sports Med 2014; 42 (07) 1628-1637
  • 47 Bui KHT, Duong TD, Nguyen NT. , et al. Symptomatic knee osteoarthritis treatment using autologous adipose derived stem cells and platelet-rich plasma: a clinical study. Biomed Res Ther 2014; 1 (01) 2-8
  • 48 Koh YG, Kwon OR, Kim YS, Choi YJ. Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: a prospective study. Arthroscopy 2014; 30 (11) 1453-1460
  • 49 Nguyen PD, Tran TD, Nguyen HT. , et al. Comparative clinical observation of arthroscopic microfracture in the presence and absence of a stromal vascular fraction injection for osteoarthritis. Stem Cells Transl Med 2017; 6 (01) 187-195
  • 50 Feng J, Doi K, Kuno S. , et al. Micronized cellular adipose matrix as a therapeutic injectable for diabetic ulcer. Regen Med 2015; 10 (06) 699-708
  • 51 Coleman SR. Structural fat grafting: more than a permanent filler. Plast Reconstr Surg 2006; 118 (3, Suppl): 108S-120S
  • 52 Russo A, Condello V, Madonna V, Guerriero M, Zorzi C. Autologous and micro-fragmented adipose tissue for the treatment of diffuse degenerative knee osteoarthritis. J Exp Orthop 2017; 4 (01) 33
  • 53 Cattaneo G, De Caro A, Napoli F, Chiapale D, Trada P, Camera A. Micro-fragmented adipose tissue injection associated with arthroscopic procedures in patients with symptomatic knee osteoarthritis. BMC Musculoskelet Disord 2018; 19 (01) 176
  • 54 Kim YS, Choi YJ, Koh YG. Mesenchymal stem cell implantation in knee osteoarthritis: an assessment of the factors influencing clinical outcomes. Am J Sports Med 2015; 43 (09) 2293-2301
  • 55 Koh YG, Jo SB, Kwon OR. , et al. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy 2013; 29 (04) 748-755
  • 56 Koh YG, Choi YJ, Kwon SK, Kim YS, Yeo JE. Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2015; 23 (05) 1308-1316
  • 57 Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee 2012; 19 (06) 902-907
  • 58 Hudetz D, Borić I, Rod E. , et al. The effect of intra-articular injection of autologous microfragmented fat tissue on proteoglycan synthesis in patients with knee osteoarthritis. Genes (Basel) 2017; 8 (10) E270